The Current Ratio as of December 2025 (TTM) for NeuroSense Therapeutics Ltd. (NRSN) is 0.71

According to NeuroSense Therapeutics Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 0.71. This represents a change of -26.23% compared to the average of 0.96 of the last 4 quarters.

NeuroSense Therapeutics Ltd. (NRSN) Historical Current Ratio (quarterly & annually)

How has NRSN Current Ratio performed in the past?

The mean historical Current Ratio of NeuroSense Therapeutics Ltd. over the last ten years is 9.53. The current 0.71 Current Ratio has changed 640.94% with respect to the historical average. Over the past ten years (40 quarters), NRSN's Current Ratio was at its highest in in the December 2021 quarter at 19.12. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

NeuroSense Therapeutics Ltd. (NRSN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of NeuroSense Therapeutics Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NeuroSense Therapeutics Ltd. (NRSN) Average Current Ratio

How has NRSN Current Ratio performed in the past?

The current Current Ratio of NeuroSense Therapeutics Ltd. (NRSN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

NeuroSense Therapeutics Ltd. (NRSN) Current Ratio vs. Peers

How is NRSN’s Current Ratio compared to its peers?

NeuroSense Therapeutics Ltd.’s Current Ratio is less than NeurAxis, Inc. (1.58), less than Klotho Neurosciences, Inc. (83.69), less than CollPlant Biotechnologies Ltd. (3.66), less than Exicure, Inc. (1.89), less than Cadrenal Therapeutics, Inc. Common Stock (3.02), less than Enlivex Therapeutics Ltd. (6.43), greater than Sonnet BioTherapeutics Holdings, Inc. (0.26), less than Minerva Neurosciences, Inc. (6.15), less than Rallybio Corporation (9.98), less than TAO Synergies Inc. (20.51),

Build a custom stock screener for NeuroSense Therapeutics Ltd. (NRSN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroSense Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeuroSense Therapeutics Ltd. (NRSN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeuroSense Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.